Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Petros Pharmaceuticals's cash was $3.49M at Jun 30, 2026. For fiscal 2025 it was $5.14M, up 198.9% from the year before. The highest annual figure on record is $23.85M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.14M | +198.9% |
| FY2024 | Dec 31, 2024 | $1.72M | -87.1% |
| FY2023 | Dec 31, 2023 | $13.34M | +41.5% |
| FY2022 | Dec 31, 2022 | $9.43M | -60.5% |
| FY2021 | Dec 31, 2021 | $23.85M | +39.1% |
| FY2020 | Dec 31, 2020 | $17.14M | +698.8% |
| FY2019 | Dec 31, 2019 | $2.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.49M | -52.4% |
| Q1 FY2026 | Mar 31, 2026 | $4.35M | -51.3% |
| Q4 FY2025 | Dec 31, 2025 | $5.14M | +198.9% |
| Q3 FY2025 | Sep 30, 2025 | $6.07M | +89.5% |
| Q2 FY2025 | Jun 30, 2025 | $7.32M | +8.5% |
| Q1 FY2025 | Mar 31, 2025 | $8.93M | -13.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.72M | -87.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.20M | -82.2% |
| Q2 FY2024 | Jun 30, 2024 | $6.75M | -8.6% |
| Q1 FY2024 | Mar 31, 2024 | $10.28M | +23.6% |
| Q4 FY2023 | Dec 31, 2023 | $13.34M | +41.5% |
| Q3 FY2023 | Sep 30, 2023 | $17.97M | +60.7% |
| Q2 FY2023 | Jun 30, 2023 | $7.38M | -44.5% |
| Q1 FY2023 | Mar 31, 2023 | $8.32M | -52.9% |
| Q4 FY2022 | Dec 31, 2022 | $9.43M | -60.5% |
| Q3 FY2022 | Sep 30, 2022 | $11.18M | +1.4% |
| Q2 FY2022 | Jun 30, 2022 | $13.30M | -8.7% |
| Q1 FY2022 | Mar 31, 2022 | $17.67M | +3.1% |
| Q4 FY2021 | Dec 31, 2021 | $23.85M | +3464.3% |
| Q2 FY2021 | Jun 30, 2021 | $11.03M | +1226.2% |
| Q1 FY2021 | Mar 31, 2021 | $14.57M | +1175.7% |
| Q4 FY2020 | Dec 31, 2020 | $17.14M | +698.8% |
| Q3 FY2020 | Sep 30, 2020 | $669.08K | – |
| Q2 FY2020 | Jun 30, 2020 | $831.76K | – |
| Q1 FY2020 | Mar 31, 2020 | $1.14M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.15M | – |
See a number that looks wrong?